Recall of BD Reti-COUNT

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by BECTON DICKINSON.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    The company Becton Dickinson withdraws from the market lot 82153 (per 31.07.04) of the in vitro diagnostic medical device called BD Reti-COUNT - reference 349204 following the absence of fluorescence with certain vials .. This device is used together with FACSCalibur, FACSat, FACScan or FACStrak flow cytometers for determining the reticulocyte count in human peripheral blood as a percentage of the total number of erythrocytes.


  • Model / Serial
  • Product Description
  • Manufacturer